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ABSTRACT
Computational Phenotype Discovery research has taken various
pragmatic approaches to disentangling phenotypes from the episodic
observations in Electronic Health Records. In this work, we use
transformation into continuous, longitudinal curves to abstract
away the sparse irregularity of the data, and we introduce proba-
bilistic independence as a guiding principle for disentangling phe-
notypes into patterns that may more closely match true patho-
physiologic mechanisms. We use the identification of liver disease
patterns that presage development of Hepatocellular Carcinoma as
a proof-of-concept demonstration.
CCS CONCEPTS
• Applied computing → Health informatics; • Computing
methodologies→ Learning latent representations.
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1 INTRODUCTION
There is growing evidence that insufficiently precise clinical diag-
noses are responsible for a large fraction of current treatment fail-
ures [1, 5, 18, 21]. The goal of Computational Phenotype Discovery
is to create a more precise set of patterns (or phenotypes) of clinically
observable variables that better represent latent pathophysiologic
mechanisms, and lead to more precise treatment decisions [14].
Electronic Health Records (EHRs) are a popular substrate for
phenotype discovery research, although the sparse, irregular, and
asynchronous nature of the observations they contain is a well-
known barrier to secondary use [4, 11, 14, 23].
A useful mental model is to consider the observations in a pa-
tient’s record to have been placed there by noisy episodic processes
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run within each of the patient’s medical conditions. But because
those conditions share a common vocabulary of observations, there
is no obvious correspondence between the observed data and the
unobserved conditions. The problem of disentangling the true la-
tent processes from the sparse and irregularly observed data is the
phenotype discovery problem.
This problem maps well to unsupervised feature learning, and
several approaches have been taken to date. Some overcome spar-
sity and irregularity by aggregating counts of events within defined
time windows, producing one learning instance per window. One
line of research in this direction unraveled latent factors with Non-
negative Matrix Factorization [6]. Another produced coarse phe-
notypes (on the granularity of ’Cardiovascular Disease’, or ’Lung
Disease’) by decomposing the count matrix into a phenotype matrix
and a densified temporal expression matrix, using constraints of
smoothness, sparsity, and nonnegativity [23]. A more ambitious
effort used stacked denoising autoencoders to decompose counts
vectors for 700, 000 patients using a large set of counted events into
a set of 500 phenotypes [17].
Other researchers have used dense time-series data from an
Intensive Care Unit to avoid the episodic data problem. One group
used denoising autoencoders as the decomposition method [9],
and another cast the problem as a supervised multi-label problem,
where clinical patterns were learned to predict the assignment of a
particular billing code [2].
In this work we make two contributions. First, we overcome the
episodic data problem by transforming each sequence of repeated
observations into a continuous longitudinal curve. We demonstrate
this transformation on the two most common data types in an EHR.
Second, we observe that while various methods have been used to
disentangle the latent phenotypes from the original basis of observa-
tions, those methods appear to have been chosen from a pragmatic
rather than a principled perspective. We propose using probabilis-
tic independence as a principled choice for that disentanglement
because it is more likely to illuminate actual disease mechanisms.
2 METHODS
2.1 Data
All data for this project was extracted from the de-identified mirror
of Vanderbilt’s Electronic Health Record, which contains admin-
istrative data, billing codes, medication exposures, laboratory test
results, and narrative text for over 2 million patients, reaching back
nearly 30 years [19]. We obtained IRB approval to use the data in
this research.
From this source, we extracted all ICD-9 billing codes and all
results from the 500 most common laboratory tests for all included
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records. We focused on patients with liver disease, although we
expected phenotypes from the full range of conditions to appear
among those patients. Inclusion criteria for a patient record were
the presence of any lab result indicating at least mild liver disease
(AST > 40, ALT > 55, or Alk Phos > 150) or the presence of at least
one ICD-9 billing code indicating Nonalcoholic Fatty Liver Disease
(571.8, 571.9, or 571.5). This retrieved 259, 000 records, from which
30, 000 were sampled at random for tractability. The ICD-9 codes
were grouped into 1, 814 Phecodes1, for a total instance dimension
of 2, 314 variables.
2.2 Longitudinal Curves
Previous work dealt with the episodic nature of medical data by
aggregating that data into observation windows, with the instance
vector containing the count of each variable’s event within that
window. That approach has an inherent trade-off between statistical
accuracy and window size. In contrast, we converted each obser-
vation sequence into a continuous longitudinal curve, for which
any point on that curve estimates the instantaneous value for a
given measure of a given variable at that point. The set of inferred
curves can then be sampled at any desired point, giving dense cross
sections to use for downstream learning. The semantics of each
curve differ with the type of data it represents.
Longitudinal curves for ICD-9 codes represent the intensity
function for a nonhomogeneous Gamma process over code-arrival
events, and can be interpreted as the instantaneous event density
in time [12]. This is a powerful representation that can account
for burstiness, regularity, or randomness of event timing, and can
provide uncertainty distributions for the inferred curves. Inferring
a full model is computationally intensive, however, so for this work
we used an approximate method that produces a similar intensity
curve, but several orders of magnitude faster2.
Longitudinal curves for laboratory test results represent a distri-
bution of latent functions that could have produced the observed
results. These were originally computed using nonstationary Gauss-
ian process regression [13]. However, this inference is also compu-
tationally intensive, so we approximated it using a smooth interpo-
lation algorithm that provides a similar mean curve, but without
an uncertainty distribution, which is not necessary for this work.
Other data types could be similarly represented by continuous
curves, but these two are the canonical types covering most of
the structured data in a patient record: event data with times and
variable labels but no values, and measurement data with times,
variable labels, and measured values.
2.3 Independence
Our second contribution is the use of probabilistic independence
as a principled means for disentangling clinical phenotypes. Our
underlying hypothesis is that distinct pathophysiologic processes
operate independently from each other, and as such would leave
probabilistically independent phenotypic fingerprints in the record.
Independence has previously been proposed as a principle for
disentangling factors of variation in deep architectures [3, 15], but
to our knowledge it has not been described as a guiding principle for
1https://phewascatalog.org/phecodes
2 https://github.com/ComputationalMedicineLab/fast_intensity
Figure 1: Preprocessing steps to produce the input dataset.
Episodic data observations (left) are converted into continu-
ous longitudinal curves (middle), which are then sampled at
random points to produce cross sections (right), which form
the dense data matrix (bottom right).
phenotype discovery. We anticipate that deep architectures using
this principle will eventually become the dominant approach to
phenotype discovery, but we do not use them in this work, because
if nothing else, the discovered phenotypes would be difficult to
unambiguously visualize and evaluate.
We chose Independent Components Analysis (ICA) [7] as an ap-
proach that isolates the principle of independence for disentangling
phenotypes and provides a linear decomposition that is easy to
directly visualize. ICA also makes the assumption that phenotype
compositions are constant in time (although the level expressed by a
given patient may change with time). This is a useful simplification
but not required by the domain problem.
One instance of prior work does use ICA in passing as an un-
optimized baseline comparison, but does not directly evaluate the
phenotypes produced [17].
2.4 Experiment Details
Records were extracted from the data source as described, and
curves were computed for each of the n = 2, 314 variables for each
patient, for the duration of each record. ICD-9 codes that did not
occur in the record produced a constant curve of zero intensity.
Lab results that did not occur in the record were filled a constant
curve with the population median value. Cross sections of each
record’s curve sets were then sampled at specific points in time
chosen uniformly at random at an average density of 1 sample per
year, givingm = 180, 369 total instances (Fig. 1).
This dataset X ∈ Rn×m was then decomposed by ICA into
X = AS , where the phenotypic patterns of interest appeared in
the columns of A, and the patient-specific expression levels ap-
peared in the rows of S . We arbitrarily set the dimension of the
phenotype space (the rank of A and S) to 500.
2.5 Evaluation
The resulting phenotypes were evaluated in two ways: first, using
clinical face validity as judged by a domain expert, and second, by
using them to investigate conditions that presage the diagnosis of
Hepatocellular Carcinoma (HCC, a type of liver cancer).
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(a) Late Hepatitis C (b) Early Nonalcoholic Cirrhosis (c) Late Nonalcoholic Cirrhosis
(d) Mild Non-alcoholic Steatohepatitis (e) Alcohol Dependence (f) HCC Precursors
Figure 2: Data-driven phenotypes include surprisingly detailed distinctions between early and late disease (a through e), and
identify patterns that presage Hepatocellular Carcinoma (HCC) by 10 years (f). The disease name in each caption was assigned
by an expert, not by the algorithm.
The HCC investigation was formulated as a learning problem
that predicts the presence of an HCC billing code in the record
exactly 10 years from the time of the cross section, given that there
is no such code before then. This is different from (and harder
than) the usual risk prediction problem, where the goal would be
to predict whether the event will occur any time over the next 10
years.
Our formulation allows us to examine the cancer disease process
in terms of our phenotypes a decade before its diagnosis. The salient
piece of the results (given adequate prediction accuracy) is an exam-
ination of the phenotypes that are important to the prediction, and
a judgment of whether they align with what is known about the
pathophysiology of HCC, and whether the results suggest anything
new about the disease.
We constructed negative instances from all records at least 10
years long that did not have an HCC diagnosis code (155.0, 155.1,
or 155.2), and positive instances from all those with at least 10
years before the earliest HCC code. Records with fewer than 10
pieces of data distributed among all ICD codes and lab values were
excluded. This produced l = 40, 398 instances, of which 197 were
positive. We formed the raw data matrix X ∈ Rn×l as above, and
then projected it into phenotype space using S = A−1X . A random
forest was trained on the phenotype expression matrix S to predict
the disease label.
3 RESULTS
The subjective evaluation of phenotype face validity was promising.
About 80 − 90% of the discovered phenotypes were clearly recog-
nizable as a specific disease pattern. Among these were several
phenotypes of mild to severe liver disease at a surprisingly high
level of differentiation (Fig. 2), such as very mild disease with only
slight changes in liver enzymes (panel d), early vs. late nonalcoholic
cirrhosis patterns (panels b and c), late-stage Hepatitis C (panel a),
and alcohol dependence (panel e). Of the non-recognizable pheno-
types (not shown, for space) many described complex laboratory
result patterns with some underlying theme, but which did not
immediately suggest an obvious disease. We interpret these pheno-
types as a positive result, because they suggest laboratory patterns
that may correspond to specific disease mechanisms, but which
have not yet been recognized, so there are no billing codes for them.
The prediction model produced an adequate 0.76 AUC, within
the range of historical results on the harder risk prediction problem.
The phenotype forerunners of HCC, identified using the feature
importance measure, are also very satisfying. The conditions in our
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list are known to eventually produce the tumor-generating envi-
ronment needed for HCC, and their order here matches known risk
factors in the US [16]. They also match exactly, and in order, the top
causes of liver transplant, which is the definitive treatment of HCC
[22]. The next three phenotypes suggest interesting mechanisms
that reflect known or suspected risk factors [8, 10, 16, 20].
4 DISCUSSION
This work introduces the use of independence for disentangling
latent phenotypes from EHR data, and it demonstrates the transfor-
mation of episodic clinical data into continuous longitudinal curves
to overcome well-known hurdles to learning from that data.
Our approach learned 500 different clinical patterns of billing
codes and laboratory values. These patterns provide a surprisingly
granular set of phenotypes that match clinical intuition, describing
some conditions at multiple stages, including subtle patterns of
mild disease as well as obvious patterns of severe disease. It is
straightforward to extend the input data to include other data types
such as medications, demographics, and concepts in the text.
A predictive model used the learned phenotypes to identify a
small set of conditions that presage liver cancer by 10 years, recov-
ering known precursors of that disease and strengthening previous
suggestions about additional risk factors. These findings suggest
(but do not prove) a reasonable correspondence to pathophysiologic
mechanisms.
The number of phenotypes and the size of the input dataset are
limited by available memory under ICA decomposition, but are
expandable by orders of magnitude using deep architectures with
suitable constraints to provide independence. Deep architectures
would also provide nonlinear decompositions, but they would be
more challenging to visualize and evaluate.
The best way of meaningfully evaluating thematch between a set
of data-driven phenotypes and true pathophysiologic processes is
currently an open question. Previous work has commonly evaluated
a set of phenotypes by their performance in a clinical prediction
model. We reject that approach because it doesn’t measure the
most important property, which is how faithfully the phenotypes
represent actual disease mechanisms. Deep prediction model per-
formance is a particularly deceptive measure, because deep models
are capable of making excellent predictions from many different
input representations, so long as those representations somehow
include sufficient information for the prediction.
In light of that open question, we evaluated our phenotypes
using subjective methods that try to assess how well the learned
phenotypes correspond to what is known about an a-priori selected
disease process, and whether they point us in interesting clini-
cal research directions. On both of these questions, our learned
phenotypes were quite promising.
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